Marchiafava-Bignami Disease: Clinical Trials

1 trial for Marchiafava-Bignami Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow Marchiafava-Bignami Disease: new trials by email Literature Review of Marchiafava-Bignami Disease trials Research Report on Marchiafava-Bignami Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy
Clemastine Fumarate, Placebo - Demyelinating Diseases, Demyelination; Corpus Callosum
Phase 1 / Phase 2Not yet recruitingUniversity of California, San Francisco442026-09-152026-03-11

Narrower conditions

Demyelinating Diseases (1)

Broader conditions

Brain Diseases (1)  ·  Brain Diseases, Metabolic (1)  ·  Central Nervous System Diseases (1)  ·  Nervous System Diseases (1)

Interventions

Clemastine (1)  ·  Sugars (1)

Sponsors

University of California, San Francisco (1)

Countries

United States (1)

Top investigators

Ari J Green, MD (1)